212 related articles for article (PubMed ID: 36376335)
1. Inhibiting ACK1-mediated phosphorylation of C-terminal Src kinase counteracts prostate cancer immune checkpoint blockade resistance.
Sridaran D; Chouhan S; Mahajan K; Renganathan A; Weimholt C; Bhagwat S; Reimers M; Kim EH; Thakur MK; Saeed MA; Pachynski RK; Seeliger MA; Miller WT; Feng FY; Mahajan NP
Nat Commun; 2022 Nov; 13(1):6929. PubMed ID: 36376335
[TBL] [Abstract][Full Text] [Related]
2. Dasatinib inhibits site-specific tyrosine phosphorylation of androgen receptor by Ack1 and Src kinases.
Liu Y; Karaca M; Zhang Z; Gioeli D; Earp HS; Whang YE
Oncogene; 2010 Jun; 29(22):3208-16. PubMed ID: 20383201
[TBL] [Abstract][Full Text] [Related]
3. Ack1-mediated androgen receptor phosphorylation modulates radiation resistance in castration-resistant prostate cancer.
Mahajan K; Coppola D; Rawal B; Chen YA; Lawrence HR; Engelman RW; Lawrence NJ; Mahajan NP
J Biol Chem; 2012 Jun; 287(26):22112-22. PubMed ID: 22566699
[TBL] [Abstract][Full Text] [Related]
4. TNK2/ACK1-mediated phosphorylation of ATP5F1A (ATP synthase F1 subunit alpha) selectively augments survival of prostate cancer while engendering mitochondrial vulnerability.
Chouhan S; Sawant M; Weimholt C; Luo J; Sprung RW; Terrado M; Mueller DM; Earp HS; Mahajan NP
Autophagy; 2023 Mar; 19(3):1000-1025. PubMed ID: 35895804
[TBL] [Abstract][Full Text] [Related]
5. ACK1/TNK2 tyrosine kinase: molecular signaling and evolving role in cancers.
Mahajan K; Mahajan NP
Oncogene; 2015 Aug; 34(32):4162-7. PubMed ID: 25347744
[TBL] [Abstract][Full Text] [Related]
6. Activated Cdc42-associated kinase Ack1 promotes prostate cancer progression via androgen receptor tyrosine phosphorylation.
Mahajan NP; Liu Y; Majumder S; Warren MR; Parker CE; Mohler JL; Earp HS; Whang YE
Proc Natl Acad Sci U S A; 2007 May; 104(20):8438-43. PubMed ID: 17494760
[TBL] [Abstract][Full Text] [Related]
7. Blockade of ACK1/TNK2 To Squelch the Survival of Prostate Cancer Stem-like Cells.
Mahajan NP; Coppola D; Kim J; Lawrence HR; Lawrence NJ; Mahajan K
Sci Rep; 2018 Jan; 8(1):1954. PubMed ID: 29386546
[TBL] [Abstract][Full Text] [Related]
8. Activity of the nonreceptor tyrosine kinase Ack1 is regulated by tyrosine phosphorylation of its Mig6 homology region.
Kan Y; Miller WT
FEBS Lett; 2022 Nov; 596(21):2808-2820. PubMed ID: 36178070
[TBL] [Abstract][Full Text] [Related]
9. Effect of Ack1 tyrosine kinase inhibitor on ligand-independent androgen receptor activity.
Mahajan K; Challa S; Coppola D; Lawrence H; Luo Y; Gevariya H; Zhu W; Chen YA; Lawrence NJ; Mahajan NP
Prostate; 2010 Sep; 70(12):1274-85. PubMed ID: 20623637
[TBL] [Abstract][Full Text] [Related]
10. Activated tyrosine kinase Ack1 promotes prostate tumorigenesis: role of Ack1 in polyubiquitination of tumor suppressor Wwox.
Mahajan NP; Whang YE; Mohler JL; Earp HS
Cancer Res; 2005 Nov; 65(22):10514-23. PubMed ID: 16288044
[TBL] [Abstract][Full Text] [Related]
11. Biochemical properties of the Cdc42-associated tyrosine kinase ACK1. Substrate specificity, authphosphorylation, and interaction with Hck.
Yokoyama N; Miller WT
J Biol Chem; 2003 Nov; 278(48):47713-23. PubMed ID: 14506255
[TBL] [Abstract][Full Text] [Related]
12. ACK1/TNK2 Regulates Histone H4 Tyr88-phosphorylation and AR Gene Expression in Castration-Resistant Prostate Cancer.
Mahajan K; Malla P; Lawrence HR; Chen Z; Kumar-Sinha C; Malik R; Shukla S; Kim J; Coppola D; Lawrence NJ; Mahajan NP
Cancer Cell; 2017 Jun; 31(6):790-803.e8. PubMed ID: 28609657
[TBL] [Abstract][Full Text] [Related]
13. Chronologically modified androgen receptor in recurrent castration-resistant prostate cancer and its therapeutic targeting.
Sawant M; Mahajan K; Renganathan A; Weimholt C; Luo J; Kukshal V; Jez JM; Jeon MS; Zhang B; Li T; Fang B; Luo Y; Lawrence NJ; Lawrence HR; Feng FY; Mahajan NP
Sci Transl Med; 2022 Jun; 14(649):eabg4132. PubMed ID: 35704598
[TBL] [Abstract][Full Text] [Related]
14. Adenovirus-mediated overexpression of C-terminal Src kinase (Csk) in type I astrocytes interferes with cell spreading and attachment to fibronectin. Correlation with tyrosine phosphorylations of paxillin and FAK.
Takayama Y; Tanaka S; Nagai K; Okada M
J Biol Chem; 1999 Jan; 274(4):2291-7. PubMed ID: 9890993
[TBL] [Abstract][Full Text] [Related]
15. Activation of the COOH-terminal Src kinase (Csk) by cAMP-dependent protein kinase inhibits signaling through the T cell receptor.
Vang T; Torgersen KM; Sundvold V; Saxena M; Levy FO; Skålhegg BS; Hansson V; Mustelin T; Taskén K
J Exp Med; 2001 Feb; 193(4):497-507. PubMed ID: 11181701
[TBL] [Abstract][Full Text] [Related]
16. Differential Targeting of Gr-MDSCs, T Cells and Prostate Cancer Cells by Dactolisib and Dasatinib.
Liu G; Jin Z; Lu X
Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32230980
[TBL] [Abstract][Full Text] [Related]
17. Small Molecules Targeting Activated Cdc42-Associated Kinase 1 (ACK1/TNK2) for the Treatment of Cancers.
Wang A; Pei J; Shuai W; Lin C; Feng L; Wang Y; Lin F; Ouyang L; Wang G
J Med Chem; 2021 Nov; 64(22):16328-16348. PubMed ID: 34735773
[TBL] [Abstract][Full Text] [Related]
18. The activation mechanism of ACK1 (activated Cdc42-associated tyrosine kinase 1).
Lin Q; Wang J; Childress C; Yang W
Biochem J; 2012 Jul; 445(2):255-64. PubMed ID: 22553920
[TBL] [Abstract][Full Text] [Related]
19. Protein-tyrosine Phosphatase and Kinase Specificity in Regulation of SRC and Breast Tumor Kinase.
Fan G; Aleem S; Yang M; Miller WT; Tonks NK
J Biol Chem; 2015 Jun; 290(26):15934-47. PubMed ID: 25897081
[TBL] [Abstract][Full Text] [Related]
20. ACK1 tyrosine kinase: targeted inhibition to block cancer cell proliferation.
Mahajan K; Mahajan NP
Cancer Lett; 2013 Sep; 338(2):185-92. PubMed ID: 23597703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
